

N4 Pharma
N4P:LNLondon Stock Exchange
Latest Coverage
Overview
Company Profile
We’re N4 Pharma, a specialist pharmaceutical company developing a novel silica nanoparticle delivery system for vaccines and therapeutics for licensing to pharmaceutical and biotech partners. This nanoparticle has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines.
Classification
SectorHealthcare
ExchangeLondon Stock Exchange
IndustryPharmaceuticals




